MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
154.12%
Quick Ratio
154.12%
Debt to Asset Ratio
64.88%
Unit: Dollar
Assets Breakdown
    • Cash
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable & accrued inter...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
8,876,353
10,505,435
6,178,021
3,806,978
Total current assets
8,876,353
10,505,435
6,178,021
-
Total assets
8,876,353
10,505,435
6,178,021
3,806,978
Accounts payable & accrued interest
5,028,500
4,509,028
4,874,489
1,108,886
Deferred compensation
-
673,819
673,819
-
Deferred compensation related party
673,819
-
-
306,281
Unreimbursed expenses related party
57,077
52,382
276,496
206,834
Total current liabilities
5,759,396
5,235,229
5,824,804
1,622,001
Total liabilities
5,759,396
5,235,229
5,824,804
1,622,001
Common stock, 0.001 par value 100,000,000 shares authorized 14,678,208 and 14,298,446 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
14,678
14,666
14,299
13,795
Additional paid-in capital
99,845,097
98,049,683
87,475,924
79,760,045
Accumulated deficit
-96,742,818
-92,794,143
-87,137,006
-77,588,863
Total stockholders equity
3,116,957
5,270,206
353,217
2,184,977
Total liabilities and stockholders equity
8,876,353
10,505,435
6,178,021
3,806,978
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$8,876,353 (184.03%↑ Y/Y)Total current assets$8,876,353 Total assets$8,876,353 (184.03%↑ Y/Y)Total liabilities andstockholders equity$8,876,353 (184.03%↑ Y/Y)Total liabilities$5,759,396 (241.68%↑ Y/Y)Total stockholdersequity$3,116,957 (116.53%↑ Y/Y)Accumulated deficit-$96,742,818 (-31.74%↓ Y/Y)Total currentliabilities$5,759,396 (241.68%↑ Y/Y)Additional paid-in capital$99,845,097 (33.37%↑ Y/Y)Common stock, 0.001 parvalue 100,000,000...$14,678 (8.94%↑ Y/Y)Accounts payable &accrued interest$5,028,500 (287.86%↑ Y/Y)Deferred compensation related party$673,819 Unreimbursed expenses related party$57,077

Greenwich LifeSciences, Inc. (GLSI)

Greenwich LifeSciences, Inc. (GLSI)